Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RG1068 in Children With Autism and GI Dysfunction
NCT00036231Phase 3Terminated
- Sponsor
- Repligen Corporation
- Start
- Apr 2002
01
Overview
A Phase 3 trial of lobeglitazone in Autism Spectrum Disorder (ASD), sponsored by Repligen Corporation. Started Apr 2002; status: terminated.
02
Drugs
lobeglitazone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00036231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036231.